Therapeutic compounds for treating dyslipidemic conditions

Compounds of Formula I and the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of: (a) Formula Ia and (b) Formula Ib are novel LXR agonists and are useful in the treatment of dyslipidemic conditions particularly depressed levels of HDL cholestero...

Full description

Saved in:
Bibliographic Details
Main Authors DROPINSKI JAMES F, JONES A. BRIAN, ONDEYKA JOHN GEORGE, ADAMS ALAN D, SINGH SHEO BUX, GUTTERIDGE CLARE E, LUI WEIGUO, SHIAFEE ALI, BOUFFARD AILEEN
Format Patent
LanguageEnglish
Published 21.06.2005
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of Formula I and the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of: (a) Formula Ia and (b) Formula Ib are novel LXR agonists and are useful in the treatment of dyslipidemic conditions particularly depressed levels of HDL cholesterol.
Bibliography:Application Number: US20020158679